Max D. Cooper, M.D., is a Georgia Research Alliance Eminent Scholar, Professor of Pathology and Laboratory Medicine and member of the Vaccine Center at the Emory University School of Medicine. Cooper obtained his medical degree and pediatric residency training at Tulane University Medical School. While at the University of Minnesota from 1963-1967 he worked with Robert Good to establish the dual nature of the immune system. With UAB graduate student Paul Kincade, he discovered antibody class switching by B cells. Dale Bockman and Cooper described the lymphoid follicle-associated epithelial “M” cells in the intestine and their transcytotic function. While on sabbatical at University College London in 1974, he worked with Martin Raff and John Owen to define the fetal liver and bone marrow origin of B cells and pre-B cells.
His laboratory currently studies the evolution of adaptive immunity and explores the use of lamprey monoclonal antibodies for diagnosis and therapy of infectious diseases and lymphoid malignancies. Cooper is a former president of the American Association of Immunologists, the Clinical Immunology Society and the Kunkel Society. He is a member of the U.S. National Academy of Sciences, the Academy of Medicine, the American Academy of Arts and Sciences, a foreign member of the French Academy of Sciences and the Royal Society of London. Honors include the Society for Experimental Biology and Medicine Founder’s Award (1966), Sandoz Prize in Immunology (1990), American College of Physicians Science Award (1994), American Association of Immunologists (AAI) Lifetime Achievement Award (2000), AAI-Dana Foundation Award in Human Immunology Research (2006), Avery-Landsteiner Prize (2008), the Robert Koch Prize (2010), AAI Excellence in Mentoring Award (2012) and the Japan Prize (2018).
Hosted by: Caetano Reis e Sousa